SCHEMBL16454787

SCHEMBL16454787

O=C(Nc1cccc(Cl)c1)c1cccn2c(-c3ccccc3F)nnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 4/20 0.54
▸ FADS1 O60427 3/20 0.48
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ P2RX1 P51575 1/20 0.46
▸ P2RX4 Q99571 1/20 0.46
▸ P2RX7 Q99572 1/20 0.46
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ RAB9A P51151 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ NLRP3 Q96P20 1/20 0.44
▸ F10 P00742 1/20 0.43
▸ GRM4 Q14833 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16454871 0.88 MEN1 (0.48) SMOMEN1KMT2ALMNATP53
SCHEMBL16454828 0.85 FADS1 (0.51) SMOFADS1MEN1KMT2AKDM4E
SCHEMBL16454858 0.84 IDO1 (0.52) SMOMEN1KMT2AALDH1A1MAPT
SCHEMBL16454872 0.83 IDO1 (0.49) SMOMEN1KMT2AKDM4ELMNA
SCHEMBL16454856 0.79 NPC1 (0.50) MEN1KMT2AMAPTLMNATP53
SCHEMBL16454823 0.79 NPC1 (0.55) SMOFADS1MEN1KMT2AKDM4E
SCHEMBL16454829 0.77 KCNK3 (0.49) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL16454854 0.77 TP53 (0.55) SMOMEN1KMT2AKDM4EALDH1A1
SCHEMBL15778871 0.76 FADS1 (0.70) FADS1MEN1KMT2AALDH1A1MAPT
SCHEMBL16454875 0.75 KCNK3 (0.53) MEN1KMT2AALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015020565-A1 SUBSTITUTED [1,2,4]TRIAZOLO[4,3-A]PYRIDINES EXHIBITING ANTAGONIST PROPERTIES TO ADENOSINE A2A RECEPTORS, AND USE THEREOF ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НЬЮВАК" (ООО "НЬЮВАК") (RU) 2015-02-12 — — WO disclosed
Send feedback